Company profile
AtriCure, Inc.
NASDAQ: ATRC · Healthcare · Medical - Instruments & Supplies
#205 of 1,418 Healthcare companies by revenue61st-percentile growth
EA Score
84B+FH 80DQ 96GM 72SS 84
v0.1 · 65/100 weight · provisional
↑ filing timeliness, disclosure history · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$552.2M
Rev growth YoY (TTM)
+15.0%
Net income (FY)
-$11.4M
Employees
1,350
as of 2026-08-09
Market cap
$2.1B
as of 2026-08-09
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$534.5M$534.5M2025
Net income-$11.4M-$11.4M2025
Operating income-$9.4M-$9.4M2025
Total assets$654.2M$654.2M2025
Liabilities$162.2M$162.2M2025
Equity$491.9M$491.9M2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY20
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Shipping and Handling100%
By geography
U [S]81%
Non Us19%
The read
What is AtriCure, Inc.’s revenue?
AtriCure, Inc. booked $534.5M in FY2025 revenue, growing 15% year over year — faster than most Healthcare companies we track, at a -2.1% net margin.
Peers · Healthcare
Hinge Health, Inc.47DBioventus Inc.66BOrganogenesis Holdings Inc.65BMirum Pharmaceuticals, Inc.64CVeracyte, Inc.82B+Inotiv, Inc.63CKey facts
CEOMichael H. Carrel
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersMason, OH
ExchangeNASDAQ: ATRC
Employees1,350
IPO date2005-08-05
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.